MX2017011312A - Metodos para la cuantificacion de los niveles de insulina por espectrometria de masas. - Google Patents

Metodos para la cuantificacion de los niveles de insulina por espectrometria de masas.

Info

Publication number
MX2017011312A
MX2017011312A MX2017011312A MX2017011312A MX2017011312A MX 2017011312 A MX2017011312 A MX 2017011312A MX 2017011312 A MX2017011312 A MX 2017011312A MX 2017011312 A MX2017011312 A MX 2017011312A MX 2017011312 A MX2017011312 A MX 2017011312A
Authority
MX
Mexico
Prior art keywords
methods
mass spectrometric
quantitation
mass spectrometry
insulin levels
Prior art date
Application number
MX2017011312A
Other languages
English (en)
Inventor
w taylor Steven
E Reitz Richard
Chen Zhaohui
J Clarke Nigel
Mcphual Michael
Original Assignee
Quest Diagnostics Invest Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Quest Diagnostics Invest Llc filed Critical Quest Diagnostics Invest Llc
Publication of MX2017011312A publication Critical patent/MX2017011312A/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G01N33/49—Blood
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/62—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating the ionisation of gases, e.g. aerosols; by investigating electric discharges, e.g. emission of cathode
    • G01N27/64—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating the ionisation of gases, e.g. aerosols; by investigating electric discharges, e.g. emission of cathode using wave or particle radiation to ionise a gas, e.g. in an ionisation chamber
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848—Methods of protein analysis involving mass spectrometry
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
    • G01N2030/8809—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample
    • G01N2030/8813—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/62—Insulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2560/00—Chemical aspects of mass spectrometric analysis of biological material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/62—Detectors specially adapted therefor
    • G01N30/72—Mass spectrometers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Ecology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Electrochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)

Abstract

Se describen métodos para determinar la cantidad de insulina en una muestra. En el presente documento se proporcionan métodos espectrométricos de masas para detectar y cuantificar insulina y péptido C en una muestra biológica al utilizar métodos de enriquecimiento y/o purificación acoplados con técnicas espectrométricas de masas en tándem o técnicas espectrométricas de masas de alta resolución/alta exactitud. También en el presente documento se proporcionan métodos espectrométricos de masas para detectar y cuantificar insulina y cadena B en una muestra biológica al utilizar métodos de enriquecimiento y/o purificación acoplados con técnicas espectrométricas de masas en tándem o técnicas espectrométricas de masas de alta resolución/alta exactitud.
MX2017011312A 2015-03-03 2016-03-03 Metodos para la cuantificacion de los niveles de insulina por espectrometria de masas. MX2017011312A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562127770P 2015-03-03 2015-03-03
US201562128236P 2015-03-04 2015-03-04
PCT/US2016/020723 WO2016141204A1 (en) 2015-03-03 2016-03-03 Methods for quantitation of insulin levels by mass spectrometry

Publications (1)

Publication Number Publication Date
MX2017011312A true MX2017011312A (es) 2018-04-30

Family

ID=56848765

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017011312A MX2017011312A (es) 2015-03-03 2016-03-03 Metodos para la cuantificacion de los niveles de insulina por espectrometria de masas.

Country Status (8)

Country Link
US (3) US10324082B2 (es)
EP (2) EP3796004B1 (es)
JP (1) JP2018511812A (es)
CN (2) CN116298029A (es)
BR (1) BR112017018821B1 (es)
CA (1) CA2978570C (es)
MX (1) MX2017011312A (es)
WO (1) WO2016141204A1 (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3091562B1 (en) 2010-12-28 2019-01-30 Quest Diagnostics Investments LLC Quantitation of insulin by mass spectrometry
US10704021B2 (en) 2012-03-15 2020-07-07 Flodesign Sonics, Inc. Acoustic perfusion devices
WO2014105858A1 (en) * 2012-12-26 2014-07-03 Quest Diagnostics Investments Incorporated C peptide detection by mass spectrometry
WO2015105955A1 (en) 2014-01-08 2015-07-16 Flodesign Sonics, Inc. Acoustophoresis device with dual acoustophoretic chamber
US10324082B2 (en) * 2015-03-03 2019-06-18 Quest Diagnostics Investments Llc Methods for quantitation of insulin levels by mass spectrometry
US11377651B2 (en) 2016-10-19 2022-07-05 Flodesign Sonics, Inc. Cell therapy processes utilizing acoustophoresis
US11708572B2 (en) 2015-04-29 2023-07-25 Flodesign Sonics, Inc. Acoustic cell separation techniques and processes
KR20180103961A (ko) * 2016-01-23 2018-09-19 바이오콘 리미티드 인슐린 유사체에 대한 생물학적 분석 방법
US11214789B2 (en) 2016-05-03 2022-01-04 Flodesign Sonics, Inc. Concentration and washing of particles with acoustics
BR112019020473A2 (pt) * 2017-03-31 2020-04-28 Quest Diagnostics Invest Llc métodos para quantificação de insulina e c-peptídeo
DK3422005T3 (da) * 2017-06-27 2020-07-27 Univ Graz Medizinische Bestemmelse af berigelser af glukosesporstoffer ved massespektrometri
CA3085784A1 (en) 2017-12-14 2019-06-20 Flodesign Sonics, Inc. Acoustic transducer driver and controller
MX2020009618A (es) 2018-03-16 2020-12-07 Quest Diagnostics Invest Llc Métodos para detectar cromogranina a por espectrometría de masas.
CN108693280A (zh) * 2018-08-23 2018-10-23 重庆美莱德生物医药有限公司 通过uplc-ms/ms定量测定生物样品中德谷胰岛素含量的方法
CN109061196A (zh) * 2018-09-25 2018-12-21 王毅超 一种基于硅纳米颗粒-质谱联合检测胰岛素的方法
CN109991351A (zh) * 2019-03-27 2019-07-09 苏州旭辉检测有限公司 一种血液样本中胰岛素类似物的检测方法
CN113906293A (zh) * 2019-05-31 2022-01-07 株式会社新日本科学 使用色谱质谱分析装置的质谱分析方法
CN113075342B (zh) * 2020-01-04 2024-02-27 东莞市东阳光仿制药研发有限公司 一种分离检测德谷胰岛素侧链有关物质的方法
CN111366646B (zh) * 2020-02-27 2022-09-23 苏州新波生物技术有限公司 一种基于免疫纯化结合质谱检测的25-羟维生素d分析方法
WO2023205281A1 (en) * 2022-04-20 2023-10-26 Siemens Healthcare Diagnostics Inc. Quantitation of alkylphenol ethoxylate compounds in aqueous samples

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5605798A (en) 1993-01-07 1997-02-25 Sequenom, Inc. DNA diagnostic based on mass spectrometry
ES2201077T3 (es) 1993-05-28 2004-03-16 Baylor College Of Medicine Metodo y espectrometro de masas para la desorcion e ionizacion de analitos.
US5772874A (en) 1995-11-02 1998-06-30 Cohesive Technologies, Inc. High performance liquid chromatography method and apparatus
ATE184702T1 (de) 1996-01-19 1999-10-15 Cohesive Tech Inc Hochleistungsflüssigchromatographieverfahren und vorrichtung
GB9717926D0 (en) 1997-08-22 1997-10-29 Micromass Ltd Methods and apparatus for tandem mass spectrometry
WO1999038194A1 (en) 1998-01-23 1999-07-29 Analytica Of Branford, Inc. Mass spectrometry from surfaces
US6680203B2 (en) 2000-07-10 2004-01-20 Esperion Therapeutics, Inc. Fourier transform mass spectrometry of complex biological samples
GB2404784B (en) 2001-03-23 2005-06-22 Thermo Finnigan Llc Mass spectrometry method and apparatus
US7196323B2 (en) 2002-02-28 2007-03-27 Metanomics Gmbh & Co. Kgaa Mass spectrometry method for analyzing mixtures of substances
AU2006235320A1 (en) 2005-04-05 2006-10-19 Protein Discovery, Inc. Improved methods and devices for concentration and fractionation of analytes for chemical analysis including Matrix-Assisted Laser Desorption/Ionization (MALDI) Mass Spectrometry (MS)
WO2006124713A2 (en) 2005-05-13 2006-11-23 Microbia, Inc. 4-biarylyl-1-phenylazetidin-2-ones
JP2009540856A (ja) 2006-06-27 2009-11-26 バイオリポックス エービー エオキシン形成の修飾物質の同定方法
KR101409436B1 (ko) 2006-11-09 2014-06-24 알콘 리서치, 리미티드 수불용성 폴리머 매트릭스를 포함하는 누점마개
WO2008150488A1 (en) 2007-06-01 2008-12-11 Laboratory Corporation Of America Holdings Methods and systems for quantification of peptides and other analytes
US20090035807A1 (en) * 2007-07-31 2009-02-05 Wyeth Analysis of polypeptide production
EP2231602A1 (en) 2007-12-13 2010-09-29 Amgen, Inc Gamma secretase modulators
US8871527B2 (en) 2008-04-29 2014-10-28 Becton, Dickinson And Company Method and system for measuring a sample to determine the presence of and optionally treat a pathologic condition
CA2763749A1 (en) 2009-06-05 2010-12-09 Mcmaster University Synthesis and use of radiolabelled insulin analogues
EP3091562B1 (en) 2010-12-28 2019-01-30 Quest Diagnostics Investments LLC Quantitation of insulin by mass spectrometry
US8669519B2 (en) 2011-12-05 2014-03-11 Quest Diagnostics Investments, Inc. Methods for detecting reverse triiodothyronine by mass spectrometry
CN103454433B (zh) * 2012-06-05 2016-08-03 许洋 一种新型检测内外源性胰岛素的免疫质谱试剂盒
WO2014105858A1 (en) 2012-12-26 2014-07-03 Quest Diagnostics Investments Incorporated C peptide detection by mass spectrometry
US10324082B2 (en) * 2015-03-03 2019-06-18 Quest Diagnostics Investments Llc Methods for quantitation of insulin levels by mass spectrometry

Also Published As

Publication number Publication date
CA2978570C (en) 2023-09-19
CA2978570A1 (en) 2016-09-09
BR112017018821A2 (pt) 2018-04-24
EP3265805A4 (en) 2018-08-15
EP3265805B1 (en) 2020-11-11
EP3265805A1 (en) 2018-01-10
CN116298029A (zh) 2023-06-23
BR112017018821B1 (pt) 2022-07-26
JP2018511812A (ja) 2018-04-26
US20160282328A1 (en) 2016-09-29
US20230184740A1 (en) 2023-06-15
CN107548460A (zh) 2018-01-05
US10324082B2 (en) 2019-06-18
US20190302095A1 (en) 2019-10-03
WO2016141204A1 (en) 2016-09-09
EP3796004A1 (en) 2021-03-24
EP3796004B1 (en) 2023-07-12
US11486874B2 (en) 2022-11-01

Similar Documents

Publication Publication Date Title
MX2017011312A (es) Metodos para la cuantificacion de los niveles de insulina por espectrometria de masas.
MX2019011775A (es) Metodos para la cuantificacion de insulina y peptido c.
WO2012092281A3 (en) Quantitation of insulin by mass spectrometry
EP3862439A3 (en) Liver cancer detection kit or device, and detection method
EP3757225A3 (en) Pancreatic cancer detection kit or device, and detection method
GB2521579A (en) Mass spectrometer, system comprising the same, and methods for determining isotopic anatomy of compounds
SI3138489T1 (sl) Komplet za določanje koncentracije analita
EP4250336A3 (en) Methods for detecting estradiol by mass spectrometry
EP3654036A3 (en) Stomach cancer biomarker and detection method
WO2018072862A8 (de) Verfahren zum auswerten von daten einer massenspektrometrie und massenspektrometrisches verfahren sowie ein maldi tof massenspektrometer
BR112013015504A2 (pt) dispositivo de amostragem para um espectrômetro de migração de íon, método para introduzir uma amostra de gás a ser detectada pelo uso do dispositivo, e, espectrômetro de migração de íon
MX2018014867A (es) Metodo de espectrometria de masa para deteccion y cuantificacion de metabolitos.
MX2018013686A (es) Abundancia fraccional de secuencias de polinucleotidos en una muestra.
WO2013026026A3 (en) Shift correction for spectral analysis
EP3612094A4 (en) DETECTION AND CORRECTION OF CHANGES TO AN ANALYT INDICATOR
MX2011003653A (es) Metodos para detectar dihidrotestosterona mediante espectrometria de masa.
BR112014012366A2 (pt) processos para a detecção de triiodotironina inversa por espectrometria de massa
EP3438277A4 (en) PROCESS FOR DETERMINING WHETHER A TEST PROCEDURE CONTAINS PHYTOPATHOGENIC MUSHROOMS OR NOT
MX2016011807A (es) Membrana sensible al magnesio para un electrodo potenciometrico de ion selectivo para medicion de magnesio ionizado y metodos de produccion y uso de la misma.
MX2015013310A (es) Metodo y reactivo para determinar metabolitos de la vitamina d.
EP3252462A4 (en) Method for measuring liquid samples, and liquid sample sensor
BR112017024043A2 (pt) sistema aparelho e método para medir concentração de íons com uma correção de desvio padrão.
BR112016000231A8 (pt) métodos para identificações de condições de separação com cromatografia de troca de íons e para análises de composições de polipeptídeos
EP3208333A4 (en) Method for detecting and quantifying target nucleic acid in test sample using novel positive control nucleic acid
MX2020001830A (es) Deteccion y cuantificacion de guanidinoacetato, creatina, y creatinina mediante espectrometria de masas.